bromocriptine vs octreotide
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of bromocriptine and octreotide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
1 The concomitant treatment of acromegalic patients with bromocriptine and octreotide led to increased plasma levels of bromocriptine (bromocriptine AUC increased about 38%).
Cycloset
Sandostatin
Bromocriptine (Cycloset) is a medicine that acts like dopamine in your body. It is used to treat conditions caused by hormone imbalances, acromegaly, and Parkinson's disease.
Octreotide is a drug that mimics a natural hormone in your body. It is used to treat certain conditions caused by too much of certain hormones.
This medicine can treat problems caused by too much prolactin, a hormone. These problems include irregular periods, lack of periods, infertility, and low sex hormone levels. It can also treat tumors that produce prolactin. Bromocriptine can also treat acromegaly (a condition where the body produces too much growth hormone) and Parkinson's disease.
Octreotide is used to lower growth hormone and insulin-like growth factor-1 in people with acromegaly who haven't responded to other treatments. It also helps manage severe diarrhea and flushing caused by carcinoid tumors. Additionally, it can treat watery diarrhea caused by VIPomas (tumors that release vasoactive intestinal peptide).
Bromocriptine works by acting like dopamine, a natural substance in the brain. It helps to lower the amount of prolactin and growth hormone in your body. In Parkinson's disease, it helps improve motor control.
This medicine works by mimicking somatostatin, a natural hormone in your body. It reduces the amount of certain hormones, like growth hormone, that your body makes. By doing this, it helps control the symptoms caused by having too much of these hormones.
- • Nausea
- • Headache
- • Dizziness
- • Fatigue
- • Lightheadedness
- • Gallbladder problems
- • Slow heart rate
- • Diarrhea
- • Loose stools
- • Nausea
- Nausea 46
- Headache 35
- Vomiting 33
- Dizziness 31
- Pyrexia 29
- Diarrhoea 526
- Death 375
- Nausea 345
- Fatigue 305
- Malignant Neoplasm Progression 235
This medicine may cause low blood pressure. Tell your doctor if you have uncontrolled high blood pressure, are sensitive to ergot alkaloids, or are allergic to bromocriptine or any of the ingredients in the tablets. If you are taking this medicine for high prolactin and become pregnant, talk to your doctor about whether to continue taking it.
Octreotide can cause heart problems, including a higher risk of certain types of heart block. Your doctor may monitor your heart if you receive this drug intravenously. It can also cause gallbladder problems, high or low blood sugar, and thyroid issues. Tell your doctor right away if you notice new or worsening symptoms.
If you are taking bromocriptine for high prolactin and become pregnant, talk to your doctor. They will help you decide whether to continue taking it. If you are taking this medicine for acromegaly, prolactinoma, or Parkinson’s disease and become pregnant, discuss with your doctor whether the therapy is still medically necessary.
There is limited information about the safety of octreotide during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if octreotide passes into breast milk, so talk to your doctor about breastfeeding while using this medicine.
How to Read This bromocriptine vs octreotide Comparison
bromocriptine is classified in the Dopamine Agonist (Diabetes) drug class, while octreotide sits within the Somatostatin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, bromocriptine has 174 submissions while octreotide has 1,786. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to octreotide can cause the levels of bromocriptine in your blood to rise. this happens because the body does not process and remove the drug as quickly as it should.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for bromocriptine or octreotide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.